Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 16, 2026.
|Slideshows|April 27, 2018
Home Use Smartphone App for Parkinson Disease
Author(s)Veronica Hackethal, MD
New technology may help patients and providers assess changes in severity of Parkinson disease symptoms more objectively.
Advertisement
Advertisement
Related to this article
A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.
The Galassia trial will evaluate the safety and tolerability of intranasal cenegermin in about 60 children with spastic cerebral palsy across Italy.
The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Clene Submits NDA Seeking Accelerated Approval for ALS Drug
2
Early Data Show Dual-Targeting CAR-T Agent CTA313 Stabilizes Progressive Multiple Sclerosis
3
CALLIPER Extension Data Show Sustained Disability Outcomes With Vidofludimus Calcium in Progressive MS
4
Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated
5